Metastatic Pancreatic Cancer With George P. Kim, MD, and Eileen M. O'Reilly, MD: Case 2 - Episode 5
What are the options for this patient going forward? Do you recommend a third-line therapy?
Metastatic Pancreatic Cancer: Case 2
Henry R was diagnosed with adenocarcinoma in the body of the pancreas when he was 64 years old, following rapid weight loss, abdominal pains, and the development of venous thrombosis.
Upfront treatment was administered with nab-paclitaxel and gemcitabine, which lasted for 4months: